C
롤링스톤
214610KOSDAQ49.5 / 100
Reference Date: 2026-10-23
Financial Score22.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Rolling Stone Co., Ltd., established in 2009, specializes in developing molecular diagnostic equipment and kits based on LabChip technology, holding patents in 17 countries. The company offers solutions for infectious disease diagnosis, A2 milk detection, immuno/biochemical diagnostic products, and is expanding into digital healthcare and fuel trading to diversify its portfolio and achieve sustainable growth.
Number of Employees
16people
Average Salary
54.3M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
1.20Industry Average 1.204.0Point
In line with industry avg
ROE
-115.23Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
6.64Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲60.5% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲24.5% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -104.4% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (1%, downtrend)
Current 2,290Won52-week high 4,61552-week low 2,255
1-month return3.0Point
1m 0% (flat)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0